These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2906088)

  • 81. The expression of schizophrenia, affective disorder and vulnerability to tardive dyskinesia in an extensive pedigree.
    Waddington JL; Youssef HA
    Br J Psychiatry; 1988 Sep; 153():376-81. PubMed ID: 2907977
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Primitive (developmental) reflexes, tardive dyskinesia and intellectual impairment in schizophrenia.
    Barnes TR; Crichton P; Nelson HE; Halstead S
    Schizophr Res; 1995 Jul; 16(1):47-52. PubMed ID: 7547644
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Drug treatment of schizophrenia. Overview of recent research.
    Marder SR; Wirshing WC; Van Putten T
    Schizophr Res; 1991; 4(2):81-90. PubMed ID: 1674883
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.
    Kleinman I; Schachter D; Jeffries J; Goldhamer P
    Hosp Community Psychiatry; 1993 Dec; 44(12):1189-91. PubMed ID: 7907571
    [No Abstract]   [Full Text] [Related]  

  • 85. Successful treatment of respiratory dyskinesia with picoTesla range magnetic fields.
    Sandyk R; Derpapas K
    Int J Neurosci; 1994 Mar; 75(1-2):91-102. PubMed ID: 7914186
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia.
    Waddington JL; Youssef HA
    Psychol Med; 1996 Jul; 26(4):681-8. PubMed ID: 8817702
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Memory impairment in schizophrenic patients with tardive dyskinesia.
    Sorokin JE; Giordani B; Mohs RC; Losonczy MF; Davidson M; Siever LJ; Ryan TA; Davis KL
    Biol Psychiatry; 1988 Jan; 23(2):129-35. PubMed ID: 3334882
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics.
    Owens DG; Johnstone EC; Frith CD
    Arch Gen Psychiatry; 1982 Apr; 39(4):452-61. PubMed ID: 6121546
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Postural myoclonus associated with long-term administration of neuroleptics in schizophrenic patients.
    Fukuzako H; Tominaga H; Izumi K; Koja T; Nomoto M; Hokazono Y; Kamei K; Fujii H; Fukuda T; Matsumoto K
    Biol Psychiatry; 1990 May; 27(10):1116-26. PubMed ID: 1971187
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The association of pineal calcification with drug-induced dystonic movements.
    Sandyk R
    Int J Neurosci; 1990 Aug; 53(2-4):217-22. PubMed ID: 1979970
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The effect of neuroleptics on cognitive and psychomotor function.
    King DJ
    Br J Psychiatry; 1990 Dec; 157():799-811. PubMed ID: 1981157
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The two-syndrome concept: origins and current status.
    Crow TJ
    Schizophr Bull; 1985; 11(3):471-86. PubMed ID: 2863873
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The relationship between ECT responsiveness and subtypes of tardive dyskinesia in bipolar patients.
    Sandyk R
    Int J Neurosci; 1990 Oct; 54(3-4):315-9. PubMed ID: 2265982
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Patterns of neuroleptic usage in continuously hospitalized chronic schizophrenic patients: evidence for development of drug tolerance.
    Sramek JJ; Gaurano V; Herrera JM; Potkin SG
    DICP; 1990 Jan; 24(1):7-10. PubMed ID: 1967862
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients.
    Cassens G; Inglis AK; Appelbaum PS; Gutheil TG
    Schizophr Bull; 1990; 16(3):477-99. PubMed ID: 1981108
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Is the social acceptability of psychiatric patients decreased by orofacial dyskinesia?
    Boumans CE; de Mooij KJ; Koch PA; van 't Hof MA; Zitman FG
    Schizophr Bull; 1994; 20(2):339-44. PubMed ID: 7916163
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Primitive (developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder: overrepresentation in patients with tardive dyskinesia.
    Youssef HA; Waddington JL
    Biol Psychiatry; 1988 Apr; 23(8):791-6. PubMed ID: 2896519
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Abnormal involuntary movements and chronic schizophrenic disorders.
    Manschreck TC; Keuthen NJ; Schneyer ML; Celada MT; Laughery J; Collins P
    Biol Psychiatry; 1990 Jan; 27(2):150-8. PubMed ID: 2294979
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Risk factors for spontaneous dyskinesia in schizophrenia.
    Fenton WS; Wyatt RJ; McGlashan TH
    Arch Gen Psychiatry; 1994 Aug; 51(8):643-50. PubMed ID: 8042913
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Poor memory, negative symptoms and abnormal movements in never-treated Indian patients with schizophrenia.
    McCreadie RG; Latha S; Thara R; Padmavathi R; Ayankaran JR
    Br J Psychiatry; 1997 Oct; 171():360-3. PubMed ID: 9373426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.